TRAW Traws Pharma, Inc.

$0.86 +5.42%

Healthcare · Pharmaceutical Preparations

Traws Pharma, Inc. (TRAW) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $13 million. Shares last traded at $0.86, 73.5% below their 52-week high. Over the past year the stock is down 49.4%. TRAW trades at a price-to-earnings ratio of 1.42, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 328.7%, above the peer median of -0.1%. Revenue grew 1134.5% year over year.

Market Cap

$13M

Shares Out

15.2M

EPS (TTM)

$5.04

P/E Ratio

0.17

P/S Ratio

4.67

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$3.25

52-Week Low

$0.65

Volume

6,828

Avg Vol (3m)

58,707.111

Performance

-30.61%

-46.06%

-60.17%

-63.39%

YTD

-35.31%

-49.39%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

29.57

SMA (50)

$1.42

SMA (200)

$1.87

Price vs SMA50

-39.51%

Price vs SMA200

-54.07%

ATR (14)

$0.16

Financials

Revenue

$3M

Net Income

$9M

Gross Margin

—

Operating Margin

-640.7%

Net Margin

328.7%

Return on Equity

-172.7%

Return on Assets

112.4%

Current Ratio

0.43

Debt / Equity

-2.54

Revenue Growth (YoY)

+1134.5%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.53	2026-05-15
FY 2024	$0.82	2026-04-15
Q3 2025	$1.53	2025-11-13
Q2 2025	$1.95	2025-08-14
Q1 2026	$2.09	2026-05-15
FY 2024	$-35.21	2026-04-15

Full earnings history →

Pharmaceutical Preparations peers

TRAW vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

1.42 / 16.82 med

-92% discount

P/S vs peers

4.67 / 3.54 med

+32% premium

Net margin vs peers

328.7% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.